V. Tsyvunin, S. Shtrygol’, I. Havrylov, D. Shtrygol’, and A. Reus, “SGLT-2 inhibitors as potential anticonvulsants: empagliflozin, but not dapagliflozin, renders a pronounced effect and potentiates the sodium valproate activity in pentylenetetrazole-induced seizures”, ScienceRise: Pharmaceutical Science, no. 5 (39), pp. 83–90, Oct. 2022.